[Autoimmune myelofibrosis with dermatomyositis]

S Sahali; J Ghosn; T Lazure; C Goujard; J-F Delfraissy; O Lambotte

doi:10.1016/j.revmed.2008.04.007

[Autoimmune myelofibrosis with dermatomyositis]

Rev Med Interne. 2009 Jan;30(1):71-3. doi: 10.1016/j.revmed.2008.04.007. Epub 2008 May 27.

[Article in French]

Authors

S Sahali¹, J Ghosn, T Lazure, C Goujard, J-F Delfraissy, O Lambotte

Affiliation

¹ Service de médecine interne, CHU de Bicêtre, AP-HP, 78, rue du Général-Leclerc, 94275 Le-Kremlin-Bicêtre, France.

PMID: 18508162
DOI: 10.1016/j.revmed.2008.04.007

Abstract

We report a second observation of autoimmune myelofibrosis associated with an inflammatory myositis in a 30-year-old female. The links between myelofibrosis and autoimmunity are discussed.

Publication types

Case Reports

MeSH terms

Adult
Anti-Inflammatory Agents / administration & dosage
Anti-Inflammatory Agents / therapeutic use
Autoimmune Diseases*
Biopsy
Dermatologic Agents / administration & dosage
Dermatologic Agents / therapeutic use
Dermatomyositis / complications*
Dermatomyositis / diagnosis
Dermatomyositis / drug therapy
Dermatomyositis / pathology
Drug Therapy, Combination
Female
Follow-Up Studies
Glucocorticoids / administration & dosage
Glucocorticoids / therapeutic use
Humans
Mycophenolic Acid / administration & dosage
Mycophenolic Acid / analogs & derivatives
Mycophenolic Acid / therapeutic use
Prednisone / administration & dosage
Prednisone / therapeutic use
Primary Myelofibrosis / complications*
Primary Myelofibrosis / immunology
Puerperal Disorders*
Time Factors

Substances

Anti-Inflammatory Agents
Dermatologic Agents
Glucocorticoids
Mycophenolic Acid
Prednisone